Literature DB >> 9545163

Famotidine-associated mental status changes.

P T Rodgers1, G R Brengel.   

Abstract

A 77-year-old man who had taken ranitidine for several years for dyspepsia was prescribed alternative therapy with famotidine 20 mg twice/day. He subsequently developed mental status changes, with confusion, disorientation, and nightmares. The symptoms dissipated after he discontinued famotidine for 2 days. He rechallenged himself and experienced return of the symptoms shortly thereafter, with additional visual hallucinations. His therapy was changed to lansoprazole, and his symptoms again disappeared and have not recurred. Case reports of central nervous system effects with other histamine2 antagonists have been published. Eight cases occurred with famotidine, all of which were in hospitalized patients receiving intravenous famotidine. We believe this is the first report of mental status changes in an ambulatory patient taking oral famotidine. The elderly may be particularly susceptible to such changes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545163

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

1.  Ranitidine-Associated Sleep Disturbance: Case Report and Review of H2 Antihistamine-Related Central Nervous System Adverse Effects.

Authors:  Tyler Werbel; Philip R Cohen
Journal:  Cureus       Date:  2018-04-03

Review 2.  Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.

Authors:  Parisa Ghasemiyeh; Negar Mortazavi; Iman Karimzadeh; Afsaneh Vazin; Laleh Mahmoudi; Ebrahim Moghimi-Sarani; Ashkan MohammadSadeghi; Mina Shahisavandi; Ali Kheradmand; Soliman Mohammadi-Samani
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.